Patent ID: 8617535

Claim:
A kit comprising a cytotherapeutic unit suitable for treatment of a patient in need of hematopoietic cells, said cytotherapeutic unit comprising at least 1% CD34 + cells within a plurality of potent cells, said cytotherapeutic unit comprising cells from a plurality of sources, wherein said plurality of potent cells comprises isolated cells that are CD34 âˆ’ , OCT-4 + , SSEA3 âˆ’ , CD10 + , CD29 + , CD38 âˆ’ , CD44 + , CD45 âˆ’ , CD54 + , CD90 + , SH2 + , SH3 + , SH4 + , SSEA4 âˆ’ , and ABC-p + , and wherein one of said plurality of sources is postpartum placental perfusate.